Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-014870

Options or other derivatives

  • Chief Accounting Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lyon Joseph Douglas Chief Accounting Officer 2024-02-09 Grant or award · Stock option (right to buy) +150,000 150,000 D
Loading xslF345X05/ownership.xml…